Most Highly Allergic People Can Be Safely Immunized Against COVID-19
Algorithm enables immunization of most individuals, with 0.7 percent developing anaphylactic reaction after one BNT162b2 dose
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.